Resources

Selected
  • 昊华科技2024年商誉
Type of publications
Regions
Diseases
380 results found
2024 ∙ ACIP
GRADE of Moderna mRNA RSV Vaccine (mResvia) in older adults
Background paper Americas United States of America older adults RSV (Respiratory syncytial virus)
2024 ∙ STIKO
Resolution on the STIKO recommendation for a standard vaccination against diseases caused by respiratory syncytial viruses (RSV) for persons ≥ 75 years of age and for the indication vaccination of persons aged 60 to 74 years with risk factors
Recommendation Europe Germany Older adults RSV (Respiratory syncytial virus)
Download:
2024 ∙ NACI
Addendum to the NACI statement on seasonal influenza vaccine for 2024-2025: Transition from quadrivalent to trivalent influenza vaccines
Recommendation Americas Canada Influenza
Download:
2024 ∙ NACI
NACI Statement on seasonal influenza vaccine for 2024–2025
Recommendation Americas Canada Influenza
Download:
2024 ∙ NACI
NACI Updated recommendations on human papillomavirus vaccines
Recommendation Americas Canada Human papillomavirus (HPV)
Download:
2024 ∙ SAGE
Extraordinary meeting of the Strategic Advisory Group of Experts on Immunization on Ebola vaccination, May 2024
Meeting report Ebola
Download:
2024 ∙ NIAC
recommendations for the passive immunisation of infants against Respiratory Synctytal Virus (RSV) during the 2024/2025 season
Recommendation Europe Ireland RSV (Respiratory syncytial virus)
Download:
2024 ∙ NIAC
Updated 2024 recommendations for COVID 19 vaccination
Recommendation Europe Ireland COVID-19
Download:
2024 ∙ Conseil Supérieur de la Santé (CSS)
Vaccination against seasonal influenza in Belgium - Winter season 2024-2025
Recommendation Europe Belgium Influenza
Download:
2024 ∙ JCVI
JCVI Horizon Scanning sub-committee - Minute of the meeting held on 05 January 2024
Agenda & Minutes Europe United Kingdom horizon scanning
Loading...